Qato, D. M., & Olfson, M. (2018). Medications With Depression as an Adverse Effect—Reply. JAMA, 320(17), 1816-1816.

Qato, D. M., Alexander, G. C., Guadamuz, J. S., & Lindau, S. T. (2018). Prescription medication use among children and adolescents in the United States. Pediatrics, 142(3).

Qato, D. M., Ozenberger, K., & Olfson, M. (2018). Prevalence of prescription medications with depression as a potential adverse effect among adults in the United States. JAMA, 319(22), 2289-2298.

Zueger, P. M., Holmes, H. M., Calip, G. S., Qato, D. M., Pickard, A. S., & Lee, T. A. (2018). Medicare part D use of older Medicare beneficiaries admitted to hospice. Journal of the American Geriatrics Society, 66(5), 937-944.

Altaweel, A. B., Abusalah, L., & Qato, D. M. (2018). Near Field Communication Detection System for Drug-Drug Interactions. Procedia Computer Science, 140, 314-323.

Dworkin, M., Chakraborty, A., Lee, S., Monahan, C., Hightow-Weidman, L., Garofalo, R., … & Jimenez, A. (2018). A realistic talking human embodied agent mobile phone intervention to promote HIV medication adherence and retention in care in young HIV-positive African American men who have sex with men: qualitative study. JMIR mHealth and uHealth, 6(7), e10211.

Qato, D. M., Alexander, G. C., Guadamuz, J. S., & Lindau, S. T. (2018). Prevalence of dietary supplement use in US children and adolescents, 2003-2014. JAMA Pediatrics, 172(8), 780-782.

Chakraborty, A., Qato, D. M., Awadalla, S., Hershow, R. C., & Dworkin, M. S. (2019). Antiretroviral therapy adherence among treatment-naive HIV-infected patients: A retrospective cohort study. AIDS.

Guadamuz, J. S., Ozenberger, K., Qato, D. M., Ko, N. Y., Saffore, C. D., Adimadhyam, S., … & Calip, G. S. (2019). Mediation analyses of socioeconomic factors determining racial differences in the treatment of diffuse large B-cell lymphoma in a cohort of older adults. Medicine, 98(46).

Zueger, P. M., Holmes, H. M., Calip, G. S., Qato, D. M., Pickard, A. S., & Lee, T. A. (2019). Older Medicare beneficiaries frequently continue medications with limited benefit following hospice admission. Journal of General Internal Medicine, 34(10), 2029-2037.

Guadamuz, J. S., Alexander, G. C., Chaudhri, T., Trotzky-Sirr, R., & Qato, D. M. (2019). Availability and cost of naloxone nasal spray at pharmacies in Philadelphia, Pennsylvania, 2017. JAMA Network Open, 2(6), e195388-e195388.

Harrington, R. L., Qato, D. M., Antoon, J. W., Caskey, R. N., Schumock, G. T., & Lee, T. A. (2019). Multimorbidity and healthcare utilization among early survivors of pediatric cancer. Pediatric Blood & Cancer, 66(6), e27655.

Qato, D. M., Alexander, G. C., Chakraborty, A., Guadamuz, J. S., & Jackson, J. W. (2019). Association between pharmacy closures and adherence to cardiovascular medications among older US adults. JAMA Network Open, 2(4), e192606-e192606.

Dworkin, M. S., Lee, S., Chakraborty, A., Monahan, C., Hightow-Weidman, L., Garofalo, R., … & Jimenez, A. (2019). Acceptability, feasibility, and preliminary efficacy of a theory-based relational embodied conversational agent mobile phone intervention to promote HIV medication adherence in young HIV-positive African American MSM. AIDS Education and Prevention, 31(1), 17-37.

Qato, D. M., Alexander, G. C., & Lindau, S. T. (2019). A More Balanced Approach to Dietary Supplement Data—Reply. JAMA Pediatrics, 173(1), 104-105.

Zueger, P. M., Holmes, H. M., Qato, D. M., Pickard, A. S., Calip, G. S., & Lee, T. A. (2019). Use of Nonpalliative Medications Following Burdensome Health Care Transitions in Hospice Patients. Medical Care, 57(1), 13-20.

Dean, L. T., Knapp, E. A., Snguon, S., Ransome, Y., Qato, D. M., & Visvanathan, K. (2019). Consumer credit, chronic disease and risk behaviours. J Epidemiol Community Health, 73(1), 73-78.

Guadamuz, J. S. (2019). Pharmacy access to naloxone: availability and cost varies. PharmacoEconomics & Outcomes News, 830, 26-15.

Guadamuz, J. S., Durazo-Arvizu, R. A., Daviglus, M. L., Calip, G. S., Nutescu, E. A. , Qato,  D. M. (2020). Citizenship Status and the Prevalence, Treatment, and Control of Cardiovascular Disease Risk Factors Among Adults in the United States, 2011-2016. Circ Cardiovasc Qual Outcomes. 2020 Mar;13(3):e006215. doi: 10.1161/CIRCOUTCOMES.119.006215. Epub 2020 Mar 10.

McCormick, C., & Qato, D. M. (2020, October). Trends in truvada (emtricitabine and tenofovir) utilization among HIV positive and HIV negative persons in the US 2011-2016. In Pharmacoepidemiology and Drug Safety (Vol. 29, pp. 255-255). 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY.

Alexander, G. C., Tajanlangit, M., Heyward, J., Mansour, O., Qato, D. M., & Stafford, R. S. (2020). Use and content of primary care office-based vs telemedicine care visits during the COVID-19 pandemic in the US. JAMA Network Open, 3(10), e2021476-e2021476.

Guadamuz, J. S., Durazo-Arvizu, R. A., Daviglus, M. L., Perreira, K. M., Calip, G. S., Nutescu, E. A., … & Qato, D. M. (2020). Immigration Status and Disparities in the Treatment of Cardiovascular Disease Risk Factors in the Hispanic Community Health Study/Study of Latinos (Visit 2, 2014–2017). American Journal of Public Health, 110(9), 1397-1404.

Guadamuz, J. S., Qato, D. M., & Alexander, G. C. (2020). Use of Risk Evaluation and Mitigation Strategies by the US Food and Drug Administration, 2008-2019. JAMA, 324(3), 299-301.

Alexander, G. C., & Qato, D. M. (2020). Ensuring access to medications in the US during the COVID-19 pandemic. JAMA, 324(1), 31-32.

Qato, D. M., Alexander, G. C., Guadamuz, J. S., Choi, S., Trotzky-Sirr, R., & Lindau, S. T. (2020). Pharmacist-Prescribed And Over-The-Counter Hormonal Contraception In Los Angeles County Retail Pharmacies: Study examines access to preventive and emergency hormonal contraception for women and girls without a physician’s prescription at Los Angeles retail pharmacies. Health Affairs, 39(7), 1219-1228.

Ozenberger, K., & Qato, D. M. (2020). PMU46 Psychotropic polypharmacy among Children, Adolescents, and Yong Adults treated with antidepressants in the United States. Value in Health, 23, S241-S242.

Guadamuz, J. S., Durazo-Arvizu, R. A., Daviglus, M. L., Calip, G. S., Nutescu, E. A., & Qato, D. M. (2020). Citizenship status and the prevalence, treatment, and control of cardiovascular disease risk factors among adults in the United States, 2011–2016. Circulation: Cardiovascular Quality and Outcomes, 13(3), e006215.

Harrington, R. L., Qato, D. M., Antoon, J. W., Caskey, R. N., Schumock, G. T., & Lee, T. A. (2020). Impact of multimorbidity subgroups on the health care use of early pediatric cancer survivors. Cancer, 126(3), 649-658.

Chakraborty, A., Hershow, R. C., Qato, D. M., Stayner, L., & Dworkin, M. S. (2020). Adherence to antiretroviral therapy among HIV patients in India: a systematic review and meta-analysis. AIDS and Behavior, 1-19.

Pathak, S., Haynes, M., Qato, D. M., & Urick, B. Y. (2020). Telepharmacy and Quality of Medication Use in Rural Areas, 2013–2019. Preventing Chronic Disease, 17.

Chakraborty, A., Qato, D. M., Awadalla, S. S., Hershow, R. C., & Dworkin, M. S. (2020). Antiretroviral therapy adherence among treatment-naive HIV-infected patients. AIDS, 34(1), 127-137.

Guadamuz, J. S., Alexander, G. C., Zenk, S. N., & Qato, D. M. (2020). Assessment of pharmacy closures in the United States from 2009 through 2015. JAMA Internal Medicine, 180(1), 157-160.

Guadamuz, J. S., Durazo, R., Morales, J. F., & Qato, D. M. (2021). Citizenship Status and Mortality Among Latinos: Analyses of the US National Health Interview Survey Linked Mortality Files. Health Services Research, 56, 90-91.

McCormick CD, Dadiomov D, Trotzky-Sirr R, Qato DM. Prevalence and distribution of high-risk prescription opioid use in the United States, 2011-2016. Pharmacoepidemiol Drug Saf. 2021 Aug 26. doi: 10.1002/pds.5349. Epub ahead of print. PMID: 34435406.

Guadamuz, J. S., Alexander, G. C., Zenk, S. N., Kanter, G. P., Wilder, J.R., & Qato, D. M. (2021). Access to Pharmacies and Pharmacy Services in New York, Los Angeles, Chicago, and Houston, 2015-2020. Journal of the American Pharmacists Association, doi: 10.1016/j.japh.2021.07.009.

Cortez C, Mansour O, Qato DM, Stafford RS, Alexander GC. Changes in Short-term, Long-term, and Preventive Care Delivery in US Office-Based and Telemedicine Visits During the COVID-19 Pandemic. JAMA Health Forum. 2021;2(7):e211529. doi:10.1001/jamahealthforum.2021.1529

Guadamuz, J. S., Wilder, J. R., Mouslim, M. C., Zenk, S. N., Alexander, G. C., & Qato, D. M. (2021). Fewer Pharmacies In Black And Hispanic/Latino Neighborhoods Compared With White Or Diverse Neighborhoods, 2007–15. Health Affairs, 40(5), 802-811.

Guadamuz, J. S., McCormick, C. D., Choi, S., Urick, B., Alexander, G. C., & Qato, D. M. (2021). Telepharmacy and medication adherence in urban areas. Journal of the American Pharmacists Association, 61(2), e100-e113.

Guadamuz, J. S., Kapoor, K., Lazo, M., Eleazar, A., Yahya, T., Kanaya, A.M., Cainzos-Achirica, M., Bilal ,U. (2021). Understanding Immigration as a Social Determinant of Health: Cardiovascular Disease in Hispanics/Latinos and South Asians in the United States. Curr Atheroscler Rep. 2021 Mar 27;23(6):25. doi: 10.1007/s11883-021-00920-9. PMID: 33772650.

Guadamuz, J. S., Durazo-Arvizu, R. A., Daviglus, M. L., Calip, G. S., Nutescu, E. A., & Qato, D. M. (2021). Statin nonadherence in Latino and noncitizen neighborhoods in New York City, Los Angeles, and Chicago, 2012-2016. Journal of the American Pharmacists Association.

Qato, D. M., Guadamuz, J. S., Al-Shehri, B., Al-Sultan, R., & Shahin, R. (2021). Pharmaceutical Sector in Palestine: An Introduction. In Handbook of Healthcare in the Arab World (pp. 1503-1523). Cham: Springer International Publishing.

Young, S., Guadamuz, J. S., Fitzgibbon, M., Buscemi, J., Odoms-Young, A., Kong, A. (2021). Society of Behavioral Medicine (SBM) does not support "Public Charge Rule" changes affecting immigrants' food security. Transl Behav Med. doi: 10.1093/tbm/ibaa137. Epub ahead of print. PMID: 33598698.

Qato, D. M., Alexander, G. C., & Lindau, S. T. (2021). Access To Birth Control At Community Pharmacies: The Authors Reply Health Affairs, 40(1), 178-178.

Guadamuz, J. S., Shooshtari, A., & Qato, D. M. (2022). Global, regional and national trends in statin utilisation in high-income and low/middle-income countries, 2015–2020. BMJ Open, 12(9), e061350.

Wong, P. J., Mosley, S. A., Ng, T. M., Shooshtari, A., Alexander, G. C., & Qato, D. M. (2022). Changes in anticoagulant and antiplatelet drug supply at US hospitals before and during the COVID-19 pandemic (2018-2021). American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxac381

Kanter, G. P., Parikh, R. B., Fisch, M. J., Debono, D., Bekelman, J., Xu, Y., … & Jacobson, M. (2022). Trends in Medically Integrated Dispensing Among Oncology Practices. JCO Oncology Practice, 18(10), e1672-e1682.

Ozenberger, K., Alexander, G. C., Shin, J. I., Whitsel, E. A., & Qato, D. M. (2022). Use of prescription medications with cardiovascular adverse effects among older adults in the United States. Pharmacoepidemiology and Drug Safety, 31(10), 1027-1038.

McCormick CD, Sullivan PS, Qato DM, Crawford SY, Schumock GT, Lee TA. Adherence and Persistence of HIV Pre-Exposure Prophylaxis use in the United States. Pharmacoepidemiol Drug Saf. 2023 Nov 8. doi: 10.1002/pds.5729. Epub ahead of print. PMID: 37937883.

Fallahi M, Guadamuz JS, Shooshtari A, Qato DM. Changes in HIV Pre-exposure Prophylaxis (PrEP) Coverage at State and County Level During the COVID-19 Pandemic in the United States. AIDS Behav. 2023 Sep 26. doi: 10.1007/s10461-023-04180-3. Epub ahead of print. PMID: 37751110.

Mccormick, C. , Sullivan, P. , Qato, D. , Crawford, S. , Schumock, G. & Lee, T. (9900). Trends of non-occupational post-exposure prophylaxis (nPEP) in the United States. AIDS, Publish Ahead of Print , doi: 10.1097/QAD.0000000000003701.

Weiner, S. G., Qato, D. M., Faust, J. S., & Clear, B. (2023). Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US. JAMA Network Open, 6(5), e2316089-e2316089. doi:10.1001/jamanetworkopen.2023.16089

Guadamuz, J. S., & Qato, D. M. (2023). Citizenship status and cost-related nonadherence in the United States, 2017–2021 Health Services Research. doi: 10.1111/1475-6773.14185. Epub ahead of print. PMID: 37259490.

Weiner, S. G., Qato, D. M., Faust, J. S., & Clear, B. (2023). Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US. JAMA Network Open, 6(5), e2316089-e2316089.

McCormick CD, Sullivan PS, Qato DM, Crawford SY, Schumock GT, Lee TA. Adherence to HIV Pre-Exposure Prophylaxis Testing Guidelines in the United States. AIDS Patient Care STDs. 2023 May 18. doi: 10.1089/apc.2023.0062. Epub ahead of print. PMID: 37204299.

Hernandez-Tamayo, C., Qato, D.M., Jewell M.P., Gounder,P.,Klausner, J.D. (2023). COVID-19 Pandemic Associated Declines and Subsequent Increases in Hepatitis C Virus Treatment Prescriptions in Los Angeles County, Clinical Infectious Diseases, 2023;, ciad050, https://doi.org/10.1093/cid/ciad050

Sharareh N, Zheutlin AR, Qato DM, Guadamuz J, Bress A, Vos RO. Access to community pharmacies based on drive time and by rurality across the contiguous United States. J Am Pharm Assoc (2003). 2024 Jan 10:S1544-3191(24)00004-9. doi: 10.1016/j.japh.2024.01.004. Epub ahead of print. PMID: 38215823.

Metkus T, Curran J, Lin S, Qato DM, Alexander GC. Assessment of the U.S. Food and Drug Administration's risk evaluation and mitigation strategy (REMS) for prasugrel (EFFIENT): A narrative review. Am Heart J Plus. 2024 Feb;38:100359. doi: 10.1016/j.ahjo.2024.100359. Epub 2024 Jan 8. PMID: 38371270; PMCID: PMC10871021.

Mirza A, Shooshtari A, Qato DM School closures and prescription medication use among children and adolescents before and during the COVID-19 pandemic in the USA, 2019–2022 BMJ Paediatrics Open 2024;8:e002632. doi: 10.1136/bmjpo-2024-002632

Qato DM, Romley JA, Myerson R, Goldman D, Fendrick AM. Shingles Vaccination in Medicare Part D After Inflation Reduction Act Elimination of Cost Sharing. JAMA. Published online May 23, 2024. doi:10.1001/jama.2024.7348

Qato DM, Shooshtari A, Cohen J, Yadav P. “Trends in Access to Essential Cancer Medicines in Low and Middle Income Countries, 2015-2020.” 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; Copenhagen, Denmark (August 24-28,2022); Oral.

Qato DM, Shooshtari A, Guadamuz JS, Ferguson L, Harrison D. “Disparities in Access to Contraceptives and Abortion Medications Between High Income and Low- and Middle-Income Countries (LMICs) Before and During The COVID-19 Pandemic, 2015-2020.” 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; Copenhagen, Denmark (August 24-28,2022); Poster.

Wong P, Mosely S, Ng TM, Shooshtari A, Alexander GC, Qato DM. “Changes in Anticoagulant and Antiplatelet Drug Supply at US Hospitals During The COVID-19 Pandemic.” 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; Copenhagen, Denmark (August 24-28,2022); Poster.

Fallahi M, Guadamuz JS, McCormick C, Qato DM. “Disparities and Changes in PReP Coverage for HIV Prevention Before and During The COVID-19 Pandemic in the U.S.” 39th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; Copenhagen, Denmark (August 24-28,2022); Poster

November 11th, 2023. Symposium: Findings From NSHAP: Social Connectedness, Health Indicators, Medication Effects, and Predicting Mortality. Oral Presentation: Jocelyn Wilder, Diane Lauderdale, Dima M. Qato. Use of Prescription Medications With Somnolence as a Potential Adverse Effect Among Older Adults in the United States. 

Gregory Calip, PharmD, MPH, PhD was an invited speaker at the Duke Margolis Center for Health Policy where he discussed about Clinical Trial Diversity on September 28th, 2023. Additional details regarding the event can be found at The State of Real-World Evidence Policy 2023 

Qato, DM, Guadamuz, J., Shooshtari, A., Alexander GC. (2023 August 25) “Use of Oral Preventive and Emergency Hormonal Contraceptives: Recent Trends and Response to  the U.S. Supreme Court's Dobbs Decision”.  International Conference on Pharmacoepidemiology & Therapeutic Risk Management; Halifax, Nova Scotia, Canada (August 23-27,2023); Oral.

Qato, DM, Tran, YY, Shooshtari, A., Ozenberger, K, Steinberg I. “Trends in the Use of Prescription Medications Among Women of Reproductive Age by Pregnancy Status in the U.S., 2009-2020”[1081]. International Conference on Pharmacoepidemiology & Therapeutic Risk Management; Halifax, Nova Scotia, Canada (August 23-27,2023); Poster

Metkus, T., Curran, J., Lin, S., Qato DM., Alexander GC., “Assessment of the U.S. Food and Drug Administration's Risk Evaluation and Mitigation Strategy (REMS) for Prasugrel (Effient)” [638]. International Conference on Pharmacoepidemiology & Therapeutic Risk Management; Halifax, Nova Scotia, Canada (August 23-27,2023); Poster

Qato DM., Shooshtari, A. “Trends and Disparities in Access to Oral Childhood Cancer Medicines in High Income and Low and Middle Income Countries, 2015-2020.” International Conference on Pharmacoepidemiology & Therapeutic Risk Management; Halifax, Nova Scotia, Canada (August 23-27,2023); Poster

Eduardo, I., Alexander, C., Guadamuz, J., Chakraborty, A., Qato, DM. (2023, June 26). National and State-Level Trends in Induced Abortion in the United States, 2019-2022 [podium presentation]. AcademyHealth 2023 Annual Research Meeting, Seattle Convention Center, Seattle, Washington.

Guadamuz, J., Qato, DM. (2023, June 27). Medicare Part D Preferred Pharmacy Networks and Risk of Pharmacy Closure, 2014-2022. [podium presentation]. AcademyHealth 2023 Annual Research Meeting, Seattle Convention Center, Seattle, Washington.

Qato, DM, Shooshtari, A., Guadamuz, J, Alexander, C. (2023, June 25). Impact of the Dobbs Decision on Access to Preventive and Emergency Oral Contraceptives Among Women and Girls in the U.S. [Poster]. AcademyHealth 2023 Annual Research Meeting, Seattle Convention Center, Seattle, Washington.

Sharareh, N., Zheutlin, A, Qato, DM, Guadamuz, J., Bress, A., Vos, R. Access to Community Pharmacies By Drive-Time in Urban, Suburban, and Rural Communities in the Contiguous United States [Poster]. AcademyHealth 2023 Annual Research Meeting, Seattle Convention Center, Seattle, Washington.

Weiner, S., Qato, DM, Faust, J. Clear, B. Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the U.S.[Poster]. AcademyHealth 2023 Annual Research Meeting, Seattle Convention Center, Seattle, Washington.